Immunostimulant Activity on Immune Cells Involved in Antiviral Response (N/A)

Immunostimulant activity on immune cells involved in antiviral response refers to the enhancement or activation of the immune system's ability to combat viral infections. This involves targeting key immune cells, such as plasmacytoid dendritic cells (pDCs), natural killer (NK) cells, CD8+ cytotoxic T lymphocytes (CTLs), and B lymphocytes, and activating molecular pathways like pattern recognition receptors (PRRs) and type I interferon signaling. Immunostimulants aim to promote early viral containment, enhance antigen presentation, and induce an antiviral state in cells. However, careful regulation is necessary to avoid excessive immune activation and potential adverse effects like cytokine storms or autoimmunity.

Other names

Antiviral ImmunostimulationImmune Enhancement for Viral InfectionsActivation of Antiviral Immunity

Activation of pattern recognition receptors (PRRs) like TLRs and RIG-I-like receptors, leading to the induction of type I interferons (IFNs) and other cytokines. IFNs activate the JAK-STAT pathway, resulting in the expression of interferon-stimulated genes (ISGs). These ISGs inhibit viral replication and promote antiviral immunity. Stimulation of immune cells like NK cells, T cells, and B cells enhances their effector functions, leading to viral clearance.